Sign In
Buy KNBIF
$0.0202
+0 (+0%)
At Close: Jul 31, 2026
Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow
04:30pm, Thursday, 13'th Apr 2023
WINNIPEG, Manitoba, April 13, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developme
Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 – Conference Call to Follow
08:30am, Thursday, 17'th Nov 2022
WINNIPEG, Manitoba, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development
Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum
04:30pm, Thursday, 13'th Oct 2022
Company presenting technologies for improving patient outcomes in wound care Company presenting technologies for improving patient outcomes in wound care
Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 – Conference Call to Follow
04:30pm, Thursday, 18'th Aug 2022
WINNIPEG, Manitoba, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developmen
Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow
08:30am, Thursday, 19'th May 2022
WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development
Kane Biotech to Release Fourth Quarter and Full Year 2021 Financial Results on March 24 – Conference Call to Follow
07:00am, Thursday, 17'th Mar 2022
WINNIPEG, Manitoba, March 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developme
Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, expanding its DispersinB® applications
01:00pm, Thursday, 10'th Feb 2022 GlobeNewswire
Bacterial biofilms on prostheses limit conventional antibiotic treatments of biofilm-based infections Bacterial biofilms on prostheses limit conventional antibiotic treatments of biofilm-based infections
Kane Biotech Announces Third Quarter 2021 Financial Results
09:00pm, Tuesday, 16'th Nov 2021 Intrado Digital Media
WINNIPEG, Manitoba, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the Company or Kane Biotech), today announced their third quarter 2021 financial results.
Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 – Conference Call to Follow
08:00am, Tuesday, 09'th Nov 2021
WINNIPEG, Manitoba, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developmen
Kane Biotech Announces New Credit Facility
08:00am, Thursday, 02'nd Sep 2021
WINNIPEG, Manitoba, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has entered into an amended and re
STEM Animal Health completes first shipment of bluestem™ oral care products to PetSmart® Canada
08:00am, Tuesday, 31'st Aug 2021
WINNIPEG, Manitoba, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that STEM Animal Health Inc., has shipped its first order of bluestem™ products to PetSmart® Canada, Canada larges
Kane Biotech Announces Second Quarter 2021 Financial Results
04:00pm, Thursday, 26'th Aug 2021
Strong pipeline of opportunities across all three strategic pillars Strong pipeline of opportunities across all three strategic pillars
Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
04:00pm, Thursday, 19'th Aug 2021
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developmen
Kane Biotech Announces Cancellation of Options and Issuance of Restricted Share Units
04:30pm, Wednesday, 21'st Jul 2021
WINNIPEG, Manitoba, July 21, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has cancelled 8,470,555 stock optio
Kane Biotech to meet investors at Whistler 2021 Capital Conference
10:00am, Tuesday, 29'th Jun 2021
CEO Marc Edwards to share developments driving momentum and interest in DispersinB® and coactiv+™, its proprietary technology platforms CEO Marc Edwards to share developments driving momentum and i
